Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.

MLA

Vahedi, H., et al. “Clinical Trial: The Effect of Amitriptyline in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome.” Alimentary Pharmacology & Therapeutics, vol. 27, no. 8, Apr. 2008, pp. 678–84. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2008.03633.x.

APA

Vahedi, H., Merat, S., Momtahen, S., Kazzazi, A. S., Ghaffari, N., Olfati, G., & Malekzadeh, R. (2008). Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 27(8), 678–684. https://doi.org/10.1111/j.1365-2036.2008.03633.x

Chicago

Vahedi, H, S Merat, S Momtahen, A S Kazzazi, N Ghaffari, G Olfati, and R Malekzadeh. 2008. “Clinical Trial: The Effect of Amitriptyline in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome.” Alimentary Pharmacology & Therapeutics 27 (8): 678–84. doi:10.1111/j.1365-2036.2008.03633.x.